Giuliano Rizzardini (G Rizzardini)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 11

Top Venues

Emerging microbes & infections

Expert opinion on drug metabolism & toxicology

Expert opinion on pharmacotherapy

Human vaccines & immunotherapeutics

Azienda Ospedaliera-Polo Universitario Luigi Sacco

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Azienda Ospedaliera-Polo Universitario Luigi Sacco Dec 28 2005

Italy

director of 1 and 2 Division Infectious Diseases :: infectious diseases

Publications

Andrea Giacomelli, Maria Elena Monti, Romualdo Grande, Letizia Oreni, Laura Galimberti, Anna Lisa Ridolfo, Cecilia Bonazzetti, Federico Sabaini, Laura Cordier, Agostino Zambelli, Giuliano Rizzardini, Massimo Galli, Spinello Antinori
The value of lamp to rule out imported malaria diagnosis: a retrospective observational study in Milan, Italy. Infectious diseases (London, England) 54 (6) (2022)
A Mancon, Alberto Rizzo, D Mileto, S Grosso, A Foschi, M Cutrera, A Capetti, I Faggion, A Anselmo, A Monte, Silvia Fillo, Giuliano Rizzardini, M R Gismondo, V Micheli
Viro-immunological evaluation in an immunocompromised patient with long-lasting SARS-CoV-2 infection. Emerging microbes & infections 11 (1) (2022)
Davide Mileto, V Micheli, Claudio Fenizia, M Cutrera, G Gagliardi, Alessandro Mancon, F Bracchitta, A De Silvestri, Giuliano Rizzardini, A Lombardi, M Biasin, M R Gismondo
Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees' sera: a preliminary evaluation. Emerging microbes & infections 11 (1) (2022)
D Mileto, Claudio Fenizia, M Cutrera, G Gagliardi, A Gigantiello, A De Silvestri, A Rizzo, Alessandro Mancon, M Bianchi, F De Poli, M Cuomo, I Burgo, M Longo, S G Rimoldi, C Pagani, S Grosso, V Micheli, Giuliano Rizzardini, R Grande, M Biasin, M R Gismondo, A Lombardi
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response. Emerging microbes & infections 10 (1) (2021)
Marco Piscaglia, Maria Vittoria Cossu, Matteo Passerini, Francesco Petri, Martina Gerbi, Chiara Fusetti, Amedeo Capetti, Giuliano Rizzardini
Emerging drugs for the treatment of HIV/AIDS: a review of 2019/2020 phase II and III trials. Expert opinion on emerging drugs 26 (3) (2021)
Francesca Bai, Chiara Aldieri, AnnaMaria Cattelan, Francesca Raumer, Eugenia Di Meco, Maria Cristina Moioli, Federica Tordato, Paola Morelli, Federica Borghi, Marco Rizzi, Evelyn Van Hauwermeiren, Francesco Castelli, Guglielmo Migliorino, Barbara Menzaghi, Giuliano Rizzardini, Annalisa Saracino, Antonio Cascio, Massimo Puoti, Antonella d'Arminio Monforte, Giulia Marchetti
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study). Expert review of anti-infective therapy 18 (12) (2020)
Amedeo Capetti, Giuliano Rizzardini
Choosing appropriate pharmacotherapy for drug-resistant HIV. Expert opinion on pharmacotherapy 20 (6) (2019)
Dario Cattaneo, Maria Vittoria Cossu, Giuliano Rizzardini
Pharmacokinetic drug evaluation of ritonavir (versus cobicistat) as adjunctive therapy in the treatment of HIV. Expert opinion on drug metabolism & toxicology 15 (11) (2019)
Dario Cattaneo, Amedeo Capetti, Giuliano Rizzardini
Drug-drug interactions of a two-drug regimen of dolutegravir and lamivudine for HIV treatment. Expert opinion on drug metabolism & toxicology 15 (3) (2019)
Vania Giacomet, Maria V Cossu, Amedeo F Capetti, GianVincenzo Zuccotti, Giuliano Rizzardini
An evaluation of elvitegravir plus cobicistat plus tenofovir alafenamide plus emtricitabine as a single-tablet regimen for the treatment of HIV in children and adolescents. Expert opinion on pharmacotherapy 20 (3) (2018)
Giovanna Orlando, Elena R Frati, Michela M Fasolo, Silvia Bianchi, Alberto Matteelli, Francesca Mazza, Giuliano Rizzardini, Antonella Amendola, Elisabetta Tanzi
Incident genital HPV infections and potential impact of HPV vaccines in adult women living with HIV/AIDS. Human vaccines & immunotherapeutics 15 (7-8) (2018)

Giuliano Rizzardini.css-eqlu8i{font-size:small;padding-left:4px;} (G Rizzardini)

Publication Activity (10 Years)

Top Topics

Top Venues

Giuliano Rizzardini (G Rizzardini)